文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

丙泊酚联合艾司氯胺酮与联合阿芬太尼用于ERCP镇静的疗效与安全性比较:随机对照试验研究方案

Sedation with propofol during ERCP: is the combination with esketamine more effective and safer than with alfentanil? Study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2017-10-11

本研究为随机对照多中心试验方案,拟纳入≥18岁、ASA分级I-III级接受ERCP的患者,随机分为丙泊酚/艾司氯胺酮组(K组)与丙泊酚/阿芬太尼组(A组)。主要结局为反映镇静有效性的丙泊酚总剂量,次要结局包括患者与内镜医师满意度及镇静相关肺部与心血管事件数。

要点

  • 比较丙泊酚联合艾司氯胺酮与联合阿芬太尼用于ERCP镇静的有效性与安全性。
  • 主要结局为丙泊酚总剂量,次要结局为满意度及镇静相关肺与心血管事件。
  • 镇静相关事件通过SpO2、呼吸频率、etCO2、心率、心律失常及无创血压监测收集。

核心结论

  • 研究旨在证明丙泊酚联合艾司氯胺酮用于ERCP患者镇静优于丙泊酚联合阿片类药物。

研究设计与样本

  • 随机对照多中心试验;纳入接受ERCP、≥18岁、ASA分级I-III级并签署书面知情同意的患者,随机分为K组(丙泊酚/艾司氯胺酮)与A组(丙泊酚/阿芬太尼)。

主要发现

  • 主要结局为反映镇静有效性的丙泊酚总剂量。
  • 次要结局为患者与内镜医师对操作的满意度及镇静相关肺部与心血管事件数。
  • 镇静相关事件数据通过记录SpO2、呼吸频率、etCO2、心率、心律失常(心电图)及无创血压测量收集。
  • 满意度参数通过操作前后及次日问卷收集。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is a gastrointestinal procedure that requires a relatively motionless patient during the intervention. Deep sedation by intravenous propofol combined with an opioid has recently become the preferred sedation technique. However, when high doses of propofol are used, side effects, namely respiratory depression, may occur. Esketamine has hypnotic, analgesic, and sympathomimetic effects. Our assumption is that a combination of propofol with esketamine reduces the dosage of individual drugs, thereby minimizing sedation side effects while keeping the same satisfaction level of patients and endoscopists. METHODS/DESIGN: The study will be performed as a randomized controlled multicenter trial. Patients undergoing ERCP, ≥ 18 years old, with American Society of Anesthesiologists (ASA) classification I-III will be randomized after written informed consent to group K (propofol/esketamine) or to group A (propofol/alfentanil). The primary outcome, reflecting effectiveness of sedation, is the total dose of propofol. Secondary outcome parameters are patients' and endoscopists' satisfaction with the procedure and the number of sedation-related pulmonary and cardiovascular events. Data on sedation-related events are collected by recording of oxygen saturation (SpO2), respiratory rate (RR), end-tidal CO2 (etCO2), heart rate (HR), arrhythmias (electrocardiogram (ECG)), and non-invasive blood pressure (NIBP) measurements. Satisfaction parameters are collected by means of questionnaires before and after the procedure and on the following day. DISCUSSION: Esketamine is known for its effective anesthetic and analgesic effects maintaining spontaneous breathing and airway reflexes. Due to an increase in sympathetic tone, hypotension and cardiac depression is less common. Unfortunately esketamine is also known for its psychotomimetic effects. We aim to demonstrate that the combination of esketamine with propofol for sedation in patients subjected to ERCP interventions is nevertheless superior to a combination of propofol with an opioid. TRIAL REGISTRATION: Nederland's Trial Register, NTR5486 . Registered on 17 September 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Eberl S, Koers L, van Hooft JE, et al. Sedation with propofol during ERCP: is the combination with esketamine more effective and safer than with alfentanil? Study protocol for a randomized controlled trial. Trials. 2017. PMID: 29020995. doi:10.1186/s13063-017-2197-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。